Abstract
Purpose
The lymph node status is one of the strongest prognostic determinants in rectal cancers. After chemoradiotherapy (CRT), lymph nodes are difficult to detect. This study aims to evaluate the feasibility of lymph node mapping in the mesorectum after CRT to analyze the pattern of metastasis spread and to assess the reliability of blue dye injection in sentinel lymph node detection.
Method
Ten patients with cN+ mid/low RCs after CRT were prospectively enrolled. The protocol scheduled intraoperative blue dye injection, surgery, and specimen examination with fat clearance technique. The mesorectum was divided into three equal “levels” (upper, middle, and lower); each level was divided into three equal “sectors” (right anterolateral, posterior, and left anterolateral). Lymph nodes were defined “small” if ≤5 mm.
Results
Two hundred seventy-six lymph nodes were retrieved in ten patients; 76.5 % were small lymph nodes. Six patients were pN+ (33 metastatic lymph nodes, 76 % small); small lymph node analysis upstaged one patient from N0 to N1 and four patients from N1 to N2. Metastasis distribution across sectors was continuous, without “skip sectors.” The blue dye detected the sentinel lymph node in all patients; in half of the cases, it was out of the tumor sector. Blue dye identified 69.7 % of metastatic lymph nodes; its sensitivity decreased together with the metastatic deposit size (84 % macrometastases, 28.6 % micrometastases, 0 % occult tumor cells; p = 0.004).
Conclusion
The fat clearance technique should be the standard pathological examination in patients with RCs after CRT; N staging was improved by small lymph node identification. Lymph node metastases have a continuous spread through mesorectal sectors. Blue dye injection is effective in sentinel lymph node detection.
Similar content being viewed by others
References
WHO (2013) World Health Organization statistical information system. WHO Mortality Database http//www3.who.int/whosis/menu.cfm. Accessed 6 Jan 2013
Colombo PE, Patani N, Bibeau F, Assenat E, Bernard MM, Senesse P, Rouanet P (2011) Clinical impact of lymph node status in rectal cancer. Surg Oncol 20(4):e227–e233
Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351
NCCN (2009) Practice guideline for rectal cancer. 1st edn. NCCN http//www.nccn.org. Accessed 6 Jan 2013
Baxter NN, Morris AM, Rothenberger DA, Tepper JE (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Bio Phys 61:426–431
Wichmann MW, Molar C, Meyer G, Strauss T, Hornung HM, Lau-Werner U, Angele MK, Schildberg FW (2002) Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 137:206–210
Saha S, Monson KM, Belchik A, Beutler T, Dan AG, Schochet E, Wiese D, Kaushal S, Ganatra B, Desai D (2004) Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial. Dis Colon Rectum 47:1767–1772
Wood TF, Saha S, Morton DL, Tsioulias GJ, Rangel D, Hutchinson W Jr, Foshag LJ, Bilchik AJ (2001) Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 8:150–157
Rullier E, Vendrely V (2011) Can mesorectal lymph node excision be avoided in rectal cancer surgery? Color Dis 13(7):37–42
Garcia-Aguilas J, Shi Q, Thomas CR Jr, Chan E, Cataldo P, Marcet J, Medich D, Pigazzi A, Oommen S, Posner MC. (2012) A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol doi:10.1245/s10434-011-1933-7
Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Color Dis 12:19.23
Kim JS, Sohn DK, Park JW, Kim DY, Chang HJ, Choi HS, Oh JH (2011) Prognostic significance of distribution of lymph node metastasis in advanced mid or low rectal cancer. J Surg Oncol 104(5):486–492
Scott KW, Grace RH, Gibbons P (1994) Five-year follow-up study of the fat clearance techinique in colorectal carcinoma. Dis Colon Rectum 37:126–128
Van der Pas MH, Meijer S, Hoekstra OS, Riphagen II, de Vet HC, Knol DL, van Grieken NC, Meijerink WJ (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12(6):540–550
Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A (1987) Metastases in small lymph nodes from colon cancer. Arch Surg 122:1253–1256
Kotanagi H, Fukuoka T, Shibata Y, Yoshioka T, Aizawa O, Saito Y, Tur GE, Koyama K (1993) The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer. J Surg Oncol 54:252–254
Leibold T, Shia J, Ruo L, Minsky BD, Akhurst T, Gollub MJ, Ginsberg MS, Larson S, Riedel E, Wong WD, Guillem JG (2008) Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 26:2106–2111
Cserni G (2002) The influence of nodal size on the staging of colorectal carcinomas. J Clin Pathol 55:386–390
Rodriguez-Bigas MA, Maamoun S, Weber TK, Penetrante RB, Blumenson LE, Petrelli NJ (1996) Clinical significance of colorectal cancer: metastases in lymph nodes <5 mm in size. Ann Surg Oncol 3:124–130
Yun-Feng Yao, Lin Wang, Yi-Qiang Liu, Ji-You Li, Jin Gu (2011) Lymph node distribution and pattern of metastases in the mesorectum following total mesorectal excision using the modified fat clearing technique. J Clin Pathol. doi: 10.1136/jclinpath-2011-200190
Toper B, Acland R, Kolodko V, Galandiuk S (2003) Mesorectal lymph nodes: their location and distribution within the mesorectum. Dis Colon Rectum 46:779–785
Canessa CE, Badìa F, Fierro S, Fiol V, Háyek G (2001) Anatomic study of the lymph nodes of the mesorectum. Dis Colon Rectum 44:1333–1336
Pezer RO, Seid VE, Bresciani EH, Proscurshim I, Pereira DD, Kruglensky D, Rawet V, Habr-Gama A, Kiss D (2008) Distribution of lymph nodes in the mesorectum: how deep is TME necessary? Tech Coloproctol 12:39–43
Pirro N, Pignodel C, Cathala P, Fabbro-Peray P, Godlewski G, Prudhomme M (2008) The number of lymph nodes is correlated with mesorectal morphometry. Surg Radiol Anat 30:297–302
Cserni G, Tarjàn M, Bori R (2001) Distance of lymph nodes from the tumour, an important feature in colorectal cancer specimens. Arch Pathol Med 125:246–249
Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K (1997) Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 184:584–588
Ono C, Yoshinaga K, Enomoto M, Sugihara K (2002) Discontinuos rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ. Dis Colon Rectum 45:744–799
Park JS, Choi GS, Kim HJ, Park SY, Park YJ, Lee SW, Xu Z, Bae HI (2011) The feasibility of an ex-vivo sentinel lymph mapping using preoperative radioisotope injection in cases of extraperitoneal rectal cancer. J Korean Soc Coloproctol 27(2):83–89
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farinella, E., Viganò, L., Fava, M.C. et al. In vivo lymph node mapping and pattern of metastasis spread in locally advanced mid/low rectal cancer after neoadjuvant chemoradiotherapy. Int J Colorectal Dis 28, 1523–1529 (2013). https://doi.org/10.1007/s00384-013-1727-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-013-1727-4